MCTC Holdings (OTC: MCTC), a science-forward, intellectual-property-focused company developing unique hemp-infusion technologies, recently filed its fourth cannabinoid-delivery technology patent (http://cnw.fm/B000e). An article discussing the company reads, “The company filed three other patents related to cannabinoid delivery systems in recent months. The first patent, which was on an edible, dissolvable film for the delivery of cannabinoids, was the product of collaboration between MCTC and Cannabis Nanosciences Inc. The companies also cooperated on the second patent, filed on cannabinoid nanoparticles combining TPGS, a water-soluble form of vitamin E. TPGS is a proven and safe bioenhancer of cannabinoids and other hydrophobic compounds. MCTC’s third patent was for a unique 3D-printed, 4-dimensional, shape-changing cannabinoid delivery system for beverages. . . . ‘We expect to continue to expand our intellectual property portfolio over the coming weeks and months as our research and development programs continue. We believe the area of cannabinoid delivery systems is one of the most exciting areas of the growing cannabinoid sciences arena,’ CEO Arman Tabatabaei added.”
To view the full article, visit http://cnw.fm/e7Eaq
About MCTC Holdings, Inc.
MCTC Holdings Inc. (OTC: MCTC) is a Delaware-registered, fully reporting and audited, publicly traded company. With the hemp industry moving quickly and a growing number of market entrants, MCTC plans to concentrate its efforts on the middle portions of the hemp value chain. The company plans to actively pursue R&D programs and productization for exotic extract isolation, bioenhancement of hemp extracts, and polymeric solid nanoparticles and nanofibers for addition into consumer products and for dermal application. The company was reorganized during June 2019 and announced its intent to enter the fast-growing hemp sector. The company is headed and managed by a group of highly experienced hemp and cannabis industry pioneers and entrepreneurs. For more information, visit the company’s website at www.CannabisGlobalinc.com.
NOTE TO INVESTORS: The latest news and updates relating to MCTC are available in the company’s newsroom at http://cnw.fm/MCTC
About CBDWire
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CBDWire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
Do you have a questions or are you interested in working with CNW? Ask Our Editor
CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com
CBDWire is part of the InvestorBrandNetwork.